January 15, 2026
Caldera Therapeutics Launches with $112.5M Funding for China-Licensed IBD Bispecific Antibody
Caldera Therapeutics; IBD; bispecific antibody; $112.5M funding; Qyuns Therapeutics; CLD-423
JPM26 Day 3: Sanofi CEO on RSV Scrutiny and Regeneron Dupixent Defense
JPM26; Sanofi; RSV; Beyfortus; Paul Hudson; FDA; vaccines; Dupixent; Regeneron
Cityblock Health Appoints New CTO and Tech-Focused Board Members to Accelerate AI-Driven Care
Cityblock Health; CTO; Alberto Lopez Toledo; board members; AI; Medicaid
Insilico Medicine Integrates Nach01 Foundation Model with Microsoft Discovery for AI-Native Drug Discovery
Insilico Medicine; Nach01; Microsoft Discovery; AI drug discovery; Azure; foundation model